In addition to investigating the selective antiproliferation effects of mc-oriP-IFNγ in vitro, the targeted antitumor effects of mc-oriP-IFNγ were assessed in NPC-xenografts. The gene discussed is IFNG; the disease is nasopharyngeal carcinoma.